相关实验视频
Updated: Jun 16, 2025

07:06
Binocular Dynamic Visual Acuity in Eyeglass-Corrected Myopic Patients
Published on: March 29, 2022
2.5K
在年轻成年人中的静态和动态瞳孔和住宿指标上,阿特罗宾的剂量依赖性影响
Barsha Lal1, Hope M Queener1, Lisa A Ostrin1
1University of Houston College of Optometry, Houston, Texas, United States.
Investigative ophthalmology & visual science
|June 10, 2025
概括
低剂量阿特罗平眼滴显著改变了年轻人的瞳孔大小和聚焦能力,在灌注后的24小时内观察到效果. 这些变化取决于所使用的氨酸度.
科学领域:
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
- 视光学测量 视光学测量 视光学测量
背景情况:
- 氨酸通常用于扩大瞳孔和循环.
- 低剂量氨酸在近视控制方面显示出潜力.
- 了解低剂量氨酸对眼睛指标的短期影响对于其临床应用至关重要.
研究的目的:
- 调查各种低剂量氨酸度对年轻成年人瞳孔和适应指标的短期影响.
- 为了确定这些影响的剂量反应关系.
主要方法:
- 这是一项双盲研究,涉及20名健康成年人 (18-35岁).
- 在一个眼睛中局部灌注安慰剂,0.01%,0.025%,0.05%,0.05%和0.1%的阿特罗宾.
- 测量静态和动态瞳孔直径和适应指标在基线,1小时和24小时.
主要成果:
- 在1小时和24小时观察到静态和动态瞳孔指标 (直径,收缩/膨胀速度) 的显著剂量依赖变化.
- 在所有阿特罗宾度中,最大适应性显著下降.
- 适应时间常数增加,而24小时的峰值适应速度下降.
结论:
- 低剂量氨酸 (0.01%-0.1%) 在年轻成年人中诱导了瞳孔和适应性的显著,剂量依赖的变化.
- 这些对眼睛指标的影响在单一滴滴后的24小时内是显而易见的.
- 这些发现突显了低剂量氨酸对视觉功能的影响.
相关概念视频
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.2K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.2K
Cholinergic Antagonists: Pharmacological Actions
1.0K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.0K
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.1K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.1K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
710
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
710
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
647
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
647
Open Angle Glaucoma: Treatment
413
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
413

